Cysteinyl Leukotriene Antagonist in Atherosclerosis Inhibition in Patients After Endovascular Treatment Due to Peripheral Arterial Disease

NCT04277702 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Peripheral Arterial Disease
Peripheral Vascular Diseases
Lower Limb Ischemia
Atherosclerosis of Artery

Interventions

DRUG: Montelukast 10mg
PROCEDURE: Endovascular treatment
DRUG: Standard anti-platelet treatment

Sponsor

Jagiellonian University